Vivani Medical, Inc. insider trading
Every open-market purchase and sale by Vivani Medical, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Insider purchases, 5 years $26.6M 13 trades by 2 insiders
3 months later: median −0.8% (−8.2% vs S&P 500) Insider sales, 5 years $0 0 trades by 0 insiders
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Vivani Medical, Inc.’s insiders pay?
From March 24, 2015 to July 16, 2026, 8 insiders reported 91 open-market purchases and 12 sales not made under a pre-set plan in Vivani Medical, Inc. After sales, the shares moved −76.5% against the index over 12 months (a negative figure means selling was the right call).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Williams Gregg | Director | 80 | — | — | 0 | — | July 16, 2026 |
| Bolck Joachim Eberhard | 10% owner | 7 | — | — | 0 | — | April 25, 2023 |
| Greenberg Robert J. | Chairman of Board | 0 | — | — | 5 | −77.8% (4) | June 6, 2016 |
| Randolph Edward David | Vice President Manufacturing | 0 | — | — | 3 | — | June 4, 2019 |
| Ripley Anne-Marie Juliette | VP of Regulatory Affairs | 0 | — | — | 3 | −74.8% (3) | December 7, 2015 |
| Dwyer Donald | Chief Business Officer | 2 | — | — | 0 | — | August 1, 2024 |
| Mendelsohn Aaron | Director | 2 | — | — | 0 | — | December 31, 2025 |
| Okland Stephen D | Chief Commercial Officer | 0 | — | — | 1 | — | June 1, 2018 |